日本2019年全国监测:血流感染MRSA分子流行病学与特征变迁
日本51家医院参与全国监测,2019年1—9月收集45家医院270株血流感染MRSA,行药敏试验和全基因组测序。SCCmec IV型已取代II型成为主要型别,且IV型分为特征不同的多个亚型。
要点
- 日本血流感染MRSA中SCCmec IV型已取代II型,主要组合型为ST8-IV(30.7%)和ST1-IV(29.6%)。
- 主要型别存在地区差异:东部以ST1-IV为主,西部以ST8-IV为主,北部以ST5-II和ST764-II为主。
- ST8-IV、ST1-IV和ST2725-IV对克林霉素和米诺环素敏感性高于ST764-II和ST5-II。
核心结论
- 本研究显示SCCmec IV型已取代SCCmec II型成为日本血流感染MRSA的主要型别,且SCCmec IV型可分为特征不同的多个亚型。
研究设计与样本
- 从日本感染症学会招募51家日本医院,收集2019年1月至9月两套以上血培养检出的MRSA分离株,行抗菌药物敏感性试验和全基因组测序以确定SCCmec与MLST型别并检测耐药基因和毒力基因。
主要发现
- 从45家医院共收集270株MRSA分离株。
- 主要组合型为ST8-IV(30.7%)、ST1-IV(29.6%)、ST2725-IV(9.5%)、ST764-II(8.1%)和ST5-II(7.8%)。
- 东部日本最常见型别为ST1-IV,西部为ST8-IV,北部为ST5-II和ST764-II,主要型别存在地区差异。
- ST8-IV、ST1-IV和ST2725-IV对克林霉素和米诺环素的敏感性高于ST764-II和ST5-II。
- ST1-IV和ST2725-IV中erm(A)的检出率分别为93.8%和100.0%;基于耐药基因和毒力基因,ST8-IV的特征不同于ST1-IV和ST2725-IV;ST8-IV存在两种特征不同的主要类型。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Some single-centre studies have reported that MRSA carrying the staphylococcal cassette chromosome mec (SCCmec) type IV has been increasing in bloodstream infections (BSIs) in Japan. Therefore, we conducted nationwide surveillance for MRSA BSIs to investigate the extent of such change across Japan. METHODS: We recruited 51 Japanese hospitals from the Japanese Association for Infectious Diseases. MRSA isolates detected in two or more sets of blood cultures were collected between January and September 2019 and subjected to antimicrobial susceptibility testing. WGS was also performed to determine SCCmec and MLST types and detect drug-resistance and virulence genes. RESULTS: Two hundred and seventy MRSA isolates were collected from 45 hospitals. The major combination types were ST8 with SCCmec type IV (ST8-IV) (30.7%), ST1-IV (29.6%), ST2725-IV (9.5%), ST764-II (8.1%) and ST5-II (7.8%). However, there were regional differences among the major types. The most common types in eastern, western and northern Japan were ST1-IV, ST8-IV, and ST5-II and ST764-II, respectively. ST8-IV, ST1-IV and ST2725-IV exhibited greater susceptibility to clindamycin and minocycline than ST764-II and ST5-II, but erm(A) was detected in 93.8% and 100.0% of ST1-IV and ST2725-IV, respectively. Based on drug-resistance and virulence genes, characteristics of ST8-IV were different from those of ST1-IV and ST2725-IV. In addition, there were two major ST8-IV types with different characteristics. CONCLUSIONS: This study revealed that SCCmec type IV replaced SCCmec type II in MRSA BSIs. In addition, SCCmec type IV was divided into several types with different characteristics.
引用
- Kaku N, Sasaki D, Ota K, et al. Changing molecular epidemiology and characteristics of MRSA isolated from bloodstream infections: nationwide surveillance in Japan in 2019. J Antimicrob Chemother. 2022. PMID: 35639590. doi:10.1093/jac/dkac154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。